Performance of prostate health index and PSA density in a diverse biopsy‐naïve cohort with mpMRI for detecting significant prostate cancer

OBJECTIVE: To compare Prostate Health Index (PHI) and prostate‐specific antigen (PSA) density as secondary tests after multiparametric magnetic resonance imaging (mpMRI) in improving the detection accuracy of Gleason grade group (GG) 2‐5 prostate cancer (PCa) and in decreasing unnecessary biopsies i...

Descripción completa

Detalles Bibliográficos
Autores principales: Carbunaru, Samuel, Stinson, James, Babajide, Rilwan, Hollowell, Courtney M. P., Yang, Ximing, Sekosan, Marin, Ferrer, Karen, Kajdacsy‐Balla, Andre, Abelleira, Josephine, Ruden, Maria, King‐Lee, Patrice, Dalton, Daniel P., Casalino, David D., Kittles, Rick A., Gann, Peter H., Schaeffer, Edward M., Murphy, Adam B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988695/
https://www.ncbi.nlm.nih.gov/pubmed/35474697
http://dx.doi.org/10.1002/bco2.91

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988695/
https://www.ncbi.nlm.nih.gov/pubmed/35474697
http://dx.doi.org/10.1002/bco2.91

Ejemplares similares